Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders

被引:3
|
作者
Archambault, Leonie [1 ]
Goyer, Marie-Eve [2 ]
Sabetti, Judith [1 ]
Perreault, Michel [1 ,3 ]
机构
[1] Douglas Hosp, Res Ctr, Montreal, PQ, Canada
[2] Univ Montreal, Dept Family Med & Emergency Med, Montreal, PQ, Canada
[3] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
关键词
Injectable opioid agonist treatment; opioid use disorders; professionals; feasibility; acceptability; ASSISTED TREATMENT; COST-EFFECTIVENESS; HEROIN; METHADONE; TRIAL; BUPRENORPHINE; BARRIERS; DRUG;
D O I
10.1080/09687637.2022.2040007
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Engagement of health care professionals represents an important factor for successful implementation of new practices. To support these professionals' involvement, it is essential to understand their perspective. This study describes the perspective of professionals in the field of opioid use disorder (OUD), in the province of Quebec (Canada), regarding appropriateness of iOAT for their patients and the obstacles to its implementation. Methods A web-based survey was conducted, with 132 OUD professionals (physicians, pharmacists, nurses and counselors). Results 80.3% of respondents report prior knowledge of iOAT, 87.6% are interested in obtaining additional information on iOAT, and 98.1% consider iOAT to be very or partially appropriate for their clientele. In terms of barriers to iOAT implementation, the main obstacles highlighted by respondents pertain to the lack of available or qualified staff, access to appropriate facilities and equipment, and patient transportation. Professionals who perceive iOAT to be very appropriate for their clientele are more likely to report a higher number of patients with biopsychosocial deterioration, to consider themselves to be very familiar with iOAT, and to work in a higher population density area. Conclusions Results highlight feasibility challenges, but support perceived appropriateness of iOAT in a sample of OUD professionals in Quebec.
引用
收藏
页码:434 / 442
页数:9
相关论文
共 50 条
  • [1] Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline
    Fairbairn, Nadia
    Ross, Josey
    Trew, Michael
    Meador, Karine
    Turnbull, Jeff
    MacDonald, Scott
    Oviedo-Joekes, Eugenia
    Le Foll, Bernard
    Goyer, Marie-Eve
    Perreault, Michel
    Sutherland, Christy
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (38) : E1049 - E1056
  • [2] Postoperative opioid misuse in patients with opioid use disorders maintained on opioid agonist treatment
    Namiranian, Khodadad
    Siglin, Jonathan
    Sorkin, John David
    Norris, Edward J.
    Aghevli, Minu
    Covington, Edward C.
    [J]. JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2020, 109 : 8 - 13
  • [3] Ethical Considerations in Use of Injectable Opioid Agonist Treatment in Pregnancy
    Weaver, Michael
    [J]. JOURNAL OF ADDICTION MEDICINE, 2021, 15 (05) : 357 - 358
  • [4] Hospital Initiated Injectable Opioid Agonist Therapy for the Treatment of Severe Opioid Use Disorder: A Case Series
    Brar, Rupinder
    Fairbairn, Nadia
    Colizza, Kate
    Ryan, Andrea
    Nolan, Seonaid
    [J]. JOURNAL OF ADDICTION MEDICINE, 2021, 15 (02) : 163 - 166
  • [5] Supervised injectable opioid agonist therapy in a supported housing setting for the treatment of severe opioid use disorder
    Brar, Rupinder
    Sutherland, Christy
    Nolan, Seonaid
    [J]. BMJ CASE REPORTS, 2019, 12 (07)
  • [6] Implementing Opioid Agonist Treatment in Correctional Facilities
    Fiscella, Kevin
    Wakeman, Sarah E.
    Beletsky, Leo
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (09) : 1153 - 1154
  • [7] Injectable pharmacotherapy for opioid use disorders (IPOD)
    Farabee, David
    Hillhouse, Maureen
    Condon, Timothy
    McCrady, Barbara
    McCollister, Kathryn
    Ling, Walter
    [J]. CONTEMPORARY CLINICAL TRIALS, 2016, 49 : 70 - 77
  • [8] Injectable opioid agonist treatment: An evolutionary concept analysis
    Haines, Marlene
    O'Byrne, Patrick
    [J]. RESEARCH IN NURSING & HEALTH, 2021, 44 (04) : 664 - 671
  • [9] Alcohol use in opioid agonist treatment
    Nolan S.
    Klimas J.
    Wood E.
    [J]. Addiction Science & Clinical Practice, 11 (1)
  • [10] Initiation of injectable opioid agonist treatment in hospital: A case report
    McAdam, Matthew
    Brar, Rupinder
    Young, Samantha
    [J]. DRUG AND ALCOHOL REVIEW, 2020, 39 (02) : 138 - 141